About Us

FSD Pharma, through its wholly-owned subsidiary FV Pharma Inc., is a licensed producer under The Cannabis Act, having received its cultivation license on October 13, 2017 and its Sale for Medical Purposes license on April 18, 2019. FSD is focused on the development of the highest quality indoor grown, pharmaceutical grade cannabis and on the research and development of novel cannabinoid-based treatments for several central nervous system disorders, including chronic pain, fibromyalgia and irritable bowel syndrome. FSD has 25,000 square feet that is licensed at its Ontario facility and expansion is currently underway.

FSD’s R&D platform is focused on cannabinoids and their potential for widespread clinical applications. FSD has a strong interest in acquiring an R&D platform with the capability of producing synthetic cannabinoids and intends to create FDA approved medications that will be commercialized internationally.


The Cobourg Plant

FSD’s wholly-owned grow facility is the former Kraft food production plant in Cobourg, Ontario, approximately an hour’s drive from Toronto.


FSD is undergoing a stage-phased development. Once complete, the facility is expected to have over 3,800,000 sq. ft of capacity to support cultivation, processing and related ancillary businesses with production in excess of 400,000 kg of cannabis per year by 2025. The facility sits on a 70-acre parcel of land of which 30 acres are currently utilized and 40 acres are available for future development.

Optimal Environment

FSD is creating a state of the art indoor hydroponic facility, optimized for large-scale, medical-grade cannabis production.

Fully Equipped

The facility has an electrical sub-station on site, natural gas lines, multiple water-intakes, rail lines directly into the facility and 26 loading docks.